Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LDHA | P00338 | 1/20 | 0.67 |
| ▸ | FPR2 | P25090 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | PPARG | P37231 | 2/20 | 0.53 |
| ▸ | PPARA | Q07869 | 1/20 | 0.53 |
| ▸ | MMP2 | P08253 | 2/20 | 0.51 |
| ▸ | MMP9 | P14780 | 2/20 | 0.51 |
| ▸ | MMP1 | P03956 | 1/20 | 0.51 |
| ▸ | MMP3 | P08254 | 1/20 | 0.51 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16063575 | 1.00 | LDHA (0.67) | LDHAFPR2KMT2ACA2PPARG | |
| SCHEMBL2029603 | 1.00 | LDHA (0.67) | LDHAFPR2KMT2ACA2PPARG | |
| Hydrochloric Acid SCHEMBL7319628 | 0.98 | LDHA (0.65) | LDHAFPR2KMT2ACA2PPARG | |
| Hydrochloric Acid SCHEMBL7319633 | 0.98 | LDHA (0.65) | LDHAFPR2KMT2ACA2PPARG | |
| SCHEMBL14942967 | 0.87 | LDHA (0.57) | LDHAFPR2KMT2AMMP2MMP9 | |
| SCHEMBL8645164 | 0.87 | LDHA (0.57) | LDHAFPR2KMT2AMMP2MMP9 | |
| SCHEMBL19545998 | 0.87 | LDHA (0.57) | LDHAFPR2KMT2AMMP2MMP9 | |
| SCHEMBL7751730 | 0.87 | LDHA (0.67) | LDHAFPR2KMT2ACA2PPARG | |
| SCHEMBL7751726 | 0.87 | LDHA (0.67) | LDHAFPR2KMT2ACA2PPARG | |
| SCHEMBL13033619 | 0.87 | LDHA (0.57) | LDHAFPR2KMT2AMMP2MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4548814-A | SOLVENT EXTRACTION | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1985-10-22 | — | — | US | claimed |
| EP-0048149-B1 | NOVEL ANTIBIOTICS, DERIVATIVES THEREOF, PROCESSES FOR THEIR EXTRACTION, AND COMPOSITIONS CONTAINING THEM | University of Illinois Foundation (US) | 1983-11-30 | — | — | EP | claimed |
| EP-0048149-A1 | Novel antibiotics, derivatives thereof, processes for their extraction, and compositions containing them | University of Illinois Foundation (US) | 1982-03-24 | — | — | EP | claimed |
| US-12637494-B2 | Method for producing peptide containing non-natural amino acid | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2026-05-26 | — | — | US | disclosed |
| US-20260001914-A1 | MACROCYCLIC PEPTIDES TARGETING KRAS | MERCK SHARP & DOHME LLC (US) | 2026-01-01 | — | — | US | disclosed |
| US-20250340916-A1 | METHOD FOR SYNTHESIZING PEPTIDES IN CELL-FREE TRANSLATION SYSTEM | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2025-11-06 | — | — | US | disclosed |
| EP-4628592-A1 | PEPTIDE PRODUCTION METHOD COMPRISING STEP FOR TRANSLATING AMINO ACID HAVING OXYGEN ATOM AT SPECIFIC POSITION | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-10-08 | — | — | EP | disclosed |
| US-12415835-B2 | Peptide-compound cyclization method | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-09-16 | — | — | US | disclosed |
| US-12391971-B2 | Method for synthesizing peptides in cell-free translation system | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-08-19 | — | — | US | disclosed |
| EP-4570371-A2 | METHOD FOR PRODUCING CYCLIC ORGANIC COMPOUND | Chugai Seiyaku Kabushiki Kaisha (JP) | 2025-06-18 | — | — | EP | disclosed |
| CN-119080856-A | Mutant tRNA for codon extension | 中外制药株式会社 | 2024-12-06 | — | — | CN | disclosed |
| US-5137870-A | Treating animal or human hosting leukemia | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1992-08-11 | — | — | US | disclosed |
| EP-0495013-A1 | HEXAPEPTIDES WITH SULPHATE ESTER GROUPS. | FISONS CORP (US) | 1992-07-22 | — | — | EP | disclosed |
| WO-1991008225-A1 | HEXAPEPTIDES WITH SULPHATE ESTER GROUPS | FISONS CORPORATION (US) | 1991-06-13 | — | — | WO | disclosed |
| US-4950649-A | TREATING DNA AND RNA VIRUSES SUCH AS HERPES, VACCINIA, COXSACKIE AND EQUINE RHINO, AND ACCUTE LEUKEMIA | UNIVERSITY OF ILLINOIS (US) | 1990-08-21 | — | — | US | disclosed |
| US-4782135-A | OLIGOPEPTIDE ANTIBIOTIC | BOARD OF TRUSTEES, UNIVERSITY OF ILLINOIS (US) | 1988-11-01 | — | — | US | disclosed |
| US-4548814-A | SOLVENT EXTRACTION | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 1985-10-22 | — | — | US | disclosed |
| US-4493796-A | ANTIBIOTICS | BOARD OF TRUSTEES, UNIV. OF ILL. (US) | 1985-01-15 | — | — | US | disclosed |
| EP-0048149-B1 | NOVEL ANTIBIOTICS, DERIVATIVES THEREOF, PROCESSES FOR THEIR EXTRACTION, AND COMPOSITIONS CONTAINING THEM | University of Illinois Foundation (US) | 1983-11-30 | — | — | EP | disclosed |
| EP-0048149-A1 | Novel antibiotics, derivatives thereof, processes for their extraction, and compositions containing them | University of Illinois Foundation (US) | 1982-03-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637494-B2 | Method for producing peptide containing non-natural amino acid | MRPL21, RPL21, RPL30 | LDHA 1374/4885FPR2 1653/4885KMT2A 2790/4885 |
| US-12391971-B2 | Method for synthesizing peptides in cell-free translation system | AARS1, NSUN3, RNGTT | LDHA 2627/4885FPR2 883/4885KMT2A 1543/4885 |
| US-20260001914-A1 | MACROCYCLIC PEPTIDES TARGETING KRAS | KRAS, NRAS, HRAS | LDHA 4318/4885FPR2 1120/4885KMT2A 2905/4885 |
| US-20250340916-A1 | METHOD FOR SYNTHESIZING PEPTIDES IN CELL-FREE TRANSLATION SYSTEM | AARS1, NSUN3, RNGTT | LDHA 2627/4885FPR2 883/4885KMT2A 1543/4885 |
| US-12415835-B2 | Peptide-compound cyclization method | VIP, NGLY1, GLP1R | LDHA 4349/4885FPR2 190/4885KMT2A 4608/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.